Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response

Virology Journal

Volumn 8, Issue , 2011, Pages

  Zhou, Bin ^a   Liu, Ke ^a   Jiang, Yan ^b   Wei, Jian Chao ^a   Chen, Pu Yan ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b Jiangsu Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Classical swine fever virus (CSFV); Glycoprotein E2; Linear B cell epitope; Multiple epitope vaccine (MEV)

Indexed keywords

CYSTEINYLLYSYLGLUTAMYLASPARTYLTYROSYLARGINYLTYROSYLALANYLISOLEUCYLSERYLSERYLTHREONYLASPARAGINYLGLUTAMYLISOLEUCYLGLYCYLLEUCYLLEUCYLGLYCYLALANYLGLYCYLGLYCYLLEUCYLTHREONINE; CYSTEINYLPHENYLALANYLARGINYLARGINYLGLUTAMYLLYSYLPROLYLPHENYLALANYLPROLYLHISTIDYLARGINYLMETHIONYLASPARTYLCYSTEINYLVALYLTHREONYLTHREONYLTHREONYLVALYLGLUTAMYLASPARAGINYLGLUTAMYLASPARTIC ACID; GLYCOPROTEIN E2; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE; EPITOPE; GLYCOPROTEIN E2, CLASSICAL SWINE FEVER VIRUS; HYBRID PROTEIN; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANAMNESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; ESCHERICHIA COLI; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PESTIVIRUS; PESTIVIRUS INFECTION; PIGLET; PROTEIN EXPRESSION; VIRUS DETECTION; ANIMAL; BLOOD; CLASSICAL SWINE FEVER; GENE EXPRESSION; GENETICS; IMMUNIZATION; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; METHODOLOGY; SURVIVAL; SWINE;

ANIMALIA; CLASSICAL SWINE FEVER VIRUS; ESCHERICHIA COLI; PROKARYOTA; SUIDAE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; EPITOPES, B-LYMPHOCYTE; ESCHERICHIA COLI; GENE EXPRESSION; IMMUNIZATION, SECONDARY; INJECTIONS, INTRAMUSCULAR; RECOMBINANT FUSION PROTEINS; SURVIVAL ANALYSIS; SWINE; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 79960858229     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-378     Document Type: Article

References (31)

1. Survival and inactivation of classical swine fever virus. Edwards S, Vet Microbiol 2000 73 175 181 10.1016/S0378-1135(00)00143-7 10785326 (Pubitemid 30227291)
2. Introduction to classical swine fever virus disease and control policy. Moennig V, Vet Microbiol 2000 73 93 102 10.1016/S0378-1135(00)00137-1 10785320 (Pubitemid 30227285)
3. Molecular characterization of pestiviruses. Meyers G, Thiel HJ, Adv Virus Res 1996 47 53 118 8895831
4. Virus taxonomy classi.cation and nomenclature of viruses: seventh report of the international committee on taxonomy of viruses. Van Regenmortel MHV, San Diego: Academic Press 2000
5. Family Flaviviridae. Wengler G, Classication and Nomenclature of Viruses. Fifth report of the International Committee on Taxonomy of Viruses Springer, Berlin, Francki RIB, Fauquet CM, Knudson DL, Brown F, 1991 223 233
6. Fifth report of the international committee on the taxonomy of virus. Francki RIB, Faquet DL, Knudson DL, Brown F, Arch Virol 1991 2223 2233
7. Characteristics of the virus. Moennig V, Classical swine fever and related viral infections Martinus Nijhoff Publishers, Boston, Mass, Liess B, 1988 55 88
8. Flaviviridae: the viruses and their replication. Lindenbach BD, Rice CM, Fields Virology Lippincott/The Williams & Wilkins Co, Philadelphia Pa, Knipe DM, Howley PM, 4 2001 991 1041
9. Processing in the pestivirus E2-NS2 region: identification of protein p7 and E2p7. Elbers K, Tautz N, Becher P, Stoll D, Rumenapf T, Thiel HJ, J Virol 1996 70 4131 4135 8648755 (Pubitemid 26157395)
10. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. König M, Lengsfeld T, Pauly T, Stark R, Thiel HJ, J Virol 1995 69 6479 6486 7666549
11. Cellular immune response to hog cholera virus (HCV): T cells of immune pigs proliferate in vitro upon stimulation with live HCV, but the E1 envelope glycoprotein is not a major T-cell antigen. Kimman TG, Bianchi AT, Wensvoort G, de Bruin TG, Meliefste C, J Virol 1993 67 2922 2927 8474180 (Pubitemid 23118895)
12. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. Rümenapf T, Stark R, Meyers G, Thiel HJ, J Virol 1991 65 589 597 1987372
13. Marker vaccine strategies and candidate CSFV marker vaccines. Dong XN, Chen YH, Vaccine 2007 25 2 205 230 10.1016/j.vaccine.2006.07.033 16934915 (Pubitemid 44873146)
14. Novel marker vaccine sagainst classical swine fever. Beer M, Reimann I, Hoffmann B, Depner K, Vaccine 2007 25 30 5665 5670 10.1016/j.vaccine.2006.12.036 17239502 (Pubitemid 47031369)
15. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia. van Rijn PA, van Gennip HGP, de Meijer EJ, Moormann RJ, J Gen Virol 1993 74 2053 2060 10.1099/0022-1317-74-10-2053 7691986 (Pubitemid 23299882)
16. Antigenic structure of envelope glycoprotein E1 of hog cholera virus. van Rijn PA, Miedema GK, Wensvoort G, van Gennip HG, Moormann RJ, J Virol 1994 68 3934 3942 7514680 (Pubitemid 24177419)
17. Candidate peptide vaccine induced protection against classical swine fever virus. Dong XN, Wei K, Liu ZQ, Chen YH, Vaccine 2002 21 3-4 167 173 10.1016/S0264-410X(02)00466-8 12450690 (Pubitemid 35350853)
18. The protective immune response induced by B cell epitope of classical swine fever virus glycoprotein E2. Liu SG, Tu CC, Wang CL, Yu XL, Wu JM, Guo SP, Shao ML, Gong Q, Zhu QH, Kong XG, J Virol Meth 2006 134 125 129 10.1016/j.jviromet.2005.12.008 (Pubitemid 44294309)
19. Fine mapping of a C-terminal linear epitope highly conserved among the major envelope glycoprotein E2 (gp51 to gp54) of deferent pestiviruses. Yu M, Wang LF, Shiell BJ, Morrissy CJ, Westbury HA, Virology 1996 222 289 292 10.1006/viro.1996.0423 8806512 (Pubitemid 26281384)
20. Deletions of Structural Glycoprotein E2 of Classical Swine Fever Virus Strain Alfort/187 Resolve a Linear Epitope of Monoclonal Antibody WH303 and the Minimal N-Terminal Domain Essential for Binding Immunoglobulin G Antibodies of a Pig Hyperimmune Serum. Lin M, Lin F, Mallory M, Clavijo A, J Virol 2000 74 11619 11625 10.1128/JVI.74.24.11619-11625.2000 11090160 (Pubitemid 32222310)
21. Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2. Dong XN, Chen YH, Vaccine 2006 24 11 1906 1913 10.1016/j.vaccine.2005.10.039 16300867 (Pubitemid 43238273)
22. Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus. Dong XN, Chen YH, Vaccine 2006 24 19 4029 4034 10.1016/j.vaccine.2006.01.003 16504346
23. Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2. Dong X N, Qi Y, Ying J, Chen X, Chen YH, Vaccine 2006 24 426 434 10.1016/j.vaccine.2005.08. 002 16154668 (Pubitemid 41832545)
24. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus. Ge FF, Qiu YF, Yang YW, Chen PY, Arch Virol 2007 152 125 135 10.1007/s00705-006-0822-z 16862385 (Pubitemid 44974620)
25. Purification and application of bacterially expressed chimeric protein E1E2 of hepatitis C virus. Xiang ZH, Cai WJ, Zhao P, Kong LB, Ye LB, Wu ZH, Protein Expr Purif 2006 49 4995 5101
26. A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Bradford MM, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
27. A Laboratory Manual. Sambrook J, Russell D, Molecular Cloning Cold Spring Harbor Laboratory Press, New York third 2001
28. The neutralizing peroxidaselinked assay for detection of antibody against swine fever virus. Terpstra C, Bloemraad M, Gielkens AL, Vet Microbiol 1984 9 113 120 10.1016/0378-1135(84)90026-9 6375112 (Pubitemid 14100222)
29. Inhibition of classical swine fever virus replication in a stable cell line by the viral capsid and Staphylococcus aureus nuclease fusion protein. Zhou B, Liu K, Wei JC, Mao X, Chen PY, J Virol Meth 2010 167 79 83 10.1016/j.jviromet.2010.03.014
30. Site-directed mutagenesis of the major antigen E2 gene of CSFV, its high level expression in Escherichia coli and the immunonicity of recombinant E2 protein. Liu SG, Yu X, Tu X, Xu X, Zhang M, Chen Y, Liu B, Chin J Biotechnol 2003 19 439 443
31. Candidate peptide vaccine induced protection against classical swine fever virus. Dong XN, Wei K, Liu ZQ, Chen YH, Vaccine 2002 21 167 173 10.1016/S0264-410X(02)00466-8 12450690 (Pubitemid 35350853)